Migdalia M. Musler, MHSA is the Chief Operating Officer for the University of Michigan – Michigan Medicine Medical Group. In her current role, she has oversight of practice operations and responsibility for establishing the clinical strategy for the ambulatory practices to improve access, capacity/resource utilization, and patient experience while growing the network. In addition, she is responsible for providing administrative leadership in developing and implementing a system-wide approach to population health to drive improved outcomes at lower costs. Migdalia’s expertise includes staff growth & development, strategic planning and business development, performance improvement strategies and funds flow development to drive changes in clinical practice. She holds her Bachelor’s degree in Biology and her Masters in Health Service Administration from the University of Michigan. With more than 15 years of progressive health care experience, she is committed to advancing care delivery models to improve the health outcomes of our communities.
The University of Michigan Medical Group is a $2B enterprise within Michigan Medicine that includes the ambulatory care network across over 40 sites, population health, ACO and the practice plan for over 2,000 full and part-time physicians.
13 – The Case for Advanced Activity-Based Costing: How Cost Accounting Technology Must Evolve to Meet the Future of Value-Based Care (Panel) (Innovation, Financial; Course Level-Advanced)
As organizations adapt to the new reimbursement landscape, there is one area that is alarmingly overlooked — the measurement of health system costs. The foundation of most health system costing is based on an outdated methodology that relies on inaccurate charge-master-assigned values. Long-accepted in the fee-for-service reimbursement world, this approach exposes you to massive insolvency risk. In the value-based reimbursement world, health systems must know their true costs to succeed.
Enter the new activity-based costing: a breakthrough methodology that allows health systems to accurately measure and assess their true costs. Supported by advanced extrapolation technologies, this methodology can place you far ahead of competitors in the value-based care market. But be careful! Not all activity-based costing is created equal (despite marketing claims to the contrary). Come learn from our panel of speakers from forward-thinking organizations that have already started to implement the new activity-based costing. Discussions may touch on questions such as:
- How are you preparing for value-based care and capitated payment models?
- Why should advanced costing improvements be a significant component of that preparation?
- What are the current costing tools on the market, and why do they potentially lead to bad decision making? Why are these tools not up to par?
- While many are claiming activity-based costing, what approach is really necessary to achieve the reality of activity-based costing?
- How does a more advanced costing system change your ability to make decisions? What are some specific examples of ways your decision making improved since you implemented advanced costing?
- What benefits do you envision in the future as a result of switching to activity-based costing? What competitive advantages do you see as a result?